|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD 9.96 Billion
|
|
CAGR
(2023-2028)
|
9.36%
|
|
Fastest
Growing Segment
|
Surgery
Sutures
|
|
Largest
Market
|
North
America
|
Market Overview
Global Bio-based Polypropylene in
Medical Devices Market has valued at USD 9.96 Billion in 2022 and anticipated to project robust growth in the
forecast period with a CAGR of 9.36% through 2028. The
global healthcare industry is undergoing a paradigm shift towards
sustainability, and the integration of bio-based materials is playing a pivotal
role in this transformation. Bio-based polypropylene (bio-PP), derived from
renewable resources, has emerged as a sustainable alternative in the production
of medical devices.
The
use of bio-based polypropylene in medical devices is driven by the increasing
awareness of environmental sustainability and the desire to reduce the carbon
footprint in the healthcare sector. Traditional polypropylene, derived from
fossil fuels, has been a mainstay in medical device manufacturing. However, the
demand for more eco-friendly alternatives has led to the exploration and
adoption of bio-based polypropylene.
One
of the primary drivers of this market is the growing emphasis on sustainable
practices in the healthcare industry. Bio-based polypropylene, derived from
renewable feedstocks such as plant-based biomass, offers a way to reduce
dependence on finite fossil resources. The medical sector's commitment to
environmental responsibility, coupled with advancements in bio-based materials,
is fostering the integration of bio-PP in various medical applications.
The
global bio-based polypropylene in medical devices market is characterized by a
conscientious shift towards sustainable solutions in the healthcare sector.
Regions such as North America, Europe, and Asia Pacific are at the forefront of
this transition, with a significant presence of medical device manufacturers
committed to adopting environmentally friendly materials.
North
America, driven by stringent environmental regulations and a focus on green
technologies, is witnessing substantial growth in the bio-based polypropylene
in medical devices market. Europe, with its robust healthcare infrastructure
and commitment to sustainable practices, is also a key contributor. Asia
Pacific, with a burgeoning healthcare sector and increasing awareness of
sustainability, presents substantial opportunities for the market's expansion.
Bio-based
polypropylene finds versatile applications in the production of various medical
devices, contributing to the overall sustainability of the healthcare industry.
One notable application is in the manufacturing of single-use medical
instruments such as syringes, IV components, and surgical instruments. The use
of bio-PP in these devices aligns with the industry's commitment to reducing
the environmental impact of medical waste.
Another
critical application is in the production of medical packaging materials.
Bio-based polypropylene is employed in the creation of sustainable and
biodegradable packaging for pharmaceuticals and medical supplies. The
eco-friendly nature of bio-PP packaging addresses concerns about the
environmental impact of traditional plastic packaging in the healthcare sector.
Several
key trends and opportunities are shaping the bio-based polypropylene in medical
devices market, reflecting the industry's response to environmental imperatives
and technological advancements. The growing trend of circular economy practices
is influencing the market, with an emphasis on the recyclability and
biodegradability of bio-based materials. Manufacturers are exploring
closed-loop systems for the recovery and recycling of bio-PP in medical devices
to minimize waste.
The
development of bio-based polypropylene with enhanced properties is a notable
trend. Research and innovation efforts are focused on improving the mechanical
and thermal characteristics of bio-PP to match or exceed those of traditional
polypropylene. This trend opens opportunities for bio-PP to be used in a
broader range of medical devices, including those requiring specific
performance attributes.
The
increasing collaboration between medical device manufacturers and bio-based
material suppliers is a significant opportunity. Partnerships and strategic
alliances enable the seamless integration of bio-PP in medical device
production, combining the expertise of both sectors to meet regulatory
standards and address specific application requirements.
While
the bio-based polypropylene in medical devices market holds promise, it faces
certain challenges that warrant consideration. One significant challenge is the
cost competitiveness of bio-PP compared to traditional polypropylene. The
production of bio-based materials often involves higher manufacturing costs,
which can impact the adoption rate, especially in cost-sensitive markets.
Regulatory
compliance and standardization pose another challenge. Ensuring that bio-PP in
medical devices meets stringent regulatory requirements and industry standards
is crucial for widespread adoption. Manufacturers need to navigate complex
regulatory landscapes to establish bio-PP as a viable and accepted material in
medical applications.
The
global bio-based polypropylene in medical devices market is at the forefront of
sustainable innovation in the healthcare sector. As the industry strives to
balance technological advancements with environmental responsibility, bio-PP
emerges as a compelling solution to reduce the environmental impact of medical
device production and disposal.
The
interconnectedness of environmental sustainability, regulatory compliance, and
material innovation underscores the complexity of the bio-based polypropylene
in the medical devices market. Overcoming challenges and seizing opportunities
will require collaboration across the healthcare and bio-based materials
sectors, fostering a comprehensive approach towards greener and more
sustainable healthcare practices.
As
the demand for eco-friendly alternatives continues to grow, the bio-based
polypropylene in medical devices market is poised for expansion. Manufacturers
that prioritize innovation, cost-effectiveness, and environmental stewardship
will play a pivotal role in shaping the future of sustainable medical device
manufacturing, contributing to a healthier planet and population.
Key Market Drivers
Increasing Demand for Sustainable
Materials is Expected to Drive the Demand for the Global Bio-based
Polypropylene in Medical Devices Market Growth
The
global bio-based polypropylene in medical devices market is poised for
substantial growth, fueled by the increasing demand for sustainable materials
in the healthcare sector. As sustainability becomes a focal point for various
industries, including medical device manufacturing, bio-based polypropylene
emerges as a viable and eco-friendly alternative to traditional petroleum-based
plastics. The unique properties of bio-based polypropylene, coupled with a
growing awareness of environmental concerns and the need for greener practices
in healthcare, are driving the demand for this bio-sourced polymer in the
production of medical devices.
One
of the primary drivers behind the surge in demand for bio-based polypropylene
in medical devices is the increasing emphasis on sustainability within the
healthcare industry. Medical devices, ranging from surgical instruments to
packaging materials, have traditionally been manufactured using conventional
plastics derived from fossil fuels. The shift towards bio-based polypropylene
aligns with the healthcare sector's commitment to reducing its environmental
impact, lowering carbon footprints, and adopting more sustainable practices.
Bio-based polypropylene is derived from renewable resources such as plant-based
feedstocks, providing a solution to the environmental challenges associated
with conventional plastics.
The
unique properties of bio-based polypropylene make it well-suited for medical
device applications. This bio-sourced polymer offers similar mechanical and
thermal properties to its petroleum-based counterpart, ensuring that medical
devices maintain the necessary performance characteristics while introducing a
more sustainable material into their composition. From disposable medical
products to durable devices, bio-based polypropylene provides a versatile and
environmentally friendly alternative without compromising functionality or
safety standards.
Furthermore,
the stringent regulations and standards governing medical device manufacturing
are driving the adoption of sustainable materials. Regulatory bodies worldwide
are increasingly focusing on environmental aspects, and healthcare providers
are seeking suppliers and manufacturers who prioritize sustainable sourcing and
production practices. Bio-based polypropylene, derived from renewable
resources, fulfills these requirements and contributes to the healthcare
industry's efforts to create a more environmentally conscious supply chain for
medical devices.
The
demand for bio-based polypropylene is particularly pronounced in single-use
medical devices and packaging. Single-use medical products, such as syringes,
vials, and disposable surgical instruments, are crucial in preventing
infections and ensuring patient safety. The transition to bio-based
polypropylene in these applications addresses concerns related to the
environmental impact of medical waste. The use of sustainable materials in
single-use medical devices aligns with the broader trend towards a circular
economy, where materials are sourced responsibly, used efficiently, and
disposed of in an environmentally friendly manner.
Moreover,
the global push for reducing plastic waste and achieving sustainability goals
has gained momentum. Bio-based polypropylene provides a solution to the
challenges posed by conventional plastics in terms of disposal and end-of-life
considerations. As medical facilities and healthcare providers aim to minimize
their environmental footprint, the adoption of bio-based polypropylene
contributes to the overall reduction of plastic waste and supports the
transition towards a more circular and sustainable healthcare system.
The
growing awareness among healthcare professionals and consumers about the
environmental impact of medical devices is a key factor driving the demand for
bio-based polypropylene. Patients and healthcare providers alike are
increasingly seeking products that align with their sustainability values. As a
result, medical device manufacturers are incorporating bio-based polypropylene
into their product portfolios to meet this demand for greener alternatives,
contributing to the positive environmental and social impact of the healthcare
industry.
In
conclusion, the increasing demand for sustainable materials, driven by
environmental awareness and regulatory considerations, is expected to drive the
growth of the global bio-based polypropylene in medical devices market. The
unique combination of performance characteristics, environmental benefits, and
adherence to regulatory standards positions bio-based polypropylene as a
compelling choice for medical device manufacturers and healthcare providers. As
the healthcare sector continues its sustainability journey, the adoption of
bio-based polypropylene is likely to expand, fostering a more environmentally
responsible approach to medical device manufacturing and contributing to the
broader global efforts towards a sustainable future.
Increasing Prevalence of Chronic
Diseases to Propels the Bio-based Polypropylene in Medical Devices Market
Growth
The
global bio-based polypropylene in medical devices market is experiencing a
significant upswing, propelled by the increasing prevalence of chronic diseases
worldwide. The rising incidence of chronic health conditions, such as
cardiovascular diseases, diabetes, and orthopedic disorders, has led to a surge
in the demand for medical devices. As the healthcare industry grapples with the
challenges posed by the growing burden of chronic diseases, bio-based
polypropylene emerges as a pivotal material in medical device manufacturing due
to its versatility, biocompatibility, and potential environmental benefits.
One
of the primary drivers behind the growing demand for bio-based polypropylene in
medical devices is the escalating prevalence of chronic diseases. Chronic
conditions, characterized by long-term persistence and the need for ongoing
medical intervention, have become a global health concern. Medical devices play
a crucial role in the diagnosis, treatment, and management of chronic diseases,
ranging from implantable devices like pacemakers to diagnostic tools and drug
delivery systems. The versatility of bio-based polypropylene makes it an
attractive choice for manufacturing a diverse range of medical devices,
addressing the multifaceted challenges posed by chronic health conditions.
The
demand for medical devices is particularly pronounced in segments such as
orthopedics, cardiovascular interventions, and diabetes management, where
chronic diseases often require specialized and ongoing medical care. Bio-based
polypropylene, with its biocompatible properties, offers advantages in the
development of implantable devices and prosthetics. It provides a material that
is well-tolerated by the human body, reducing the risk of adverse reactions and
supporting the long-term functionality of medical implants. In orthopedics, for
example, bio-based polypropylene can be utilized in the fabrication of joint
replacements and supportive devices, contributing to improved patient outcomes
and quality of life.
Cardiovascular
diseases, which constitute a major component of chronic conditions, necessitate
the use of sophisticated medical devices for diagnosis and treatment. Bio-based
polypropylene finds application in the production of cardiovascular implants, stents,
and diagnostic tools due to its mechanical strength, flexibility, and
compatibility with the cardiovascular system. As the global burden of
cardiovascular diseases continues to rise, the demand for bio-based
polypropylene in cardiovascular medical devices is expected to grow, supporting
advancements in treatment modalities and interventions.
The
management of diabetes, another prevalent chronic disease, involves the use of
various medical devices, including insulin delivery systems and continuous
glucose monitoring devices. Bio-based polypropylene's suitability for contact
with bodily fluids, along with its potential to offer a more sustainable
option, positions it as a valuable material in the development of
diabetes-related medical devices. As the number of individuals with diabetes
increases globally, the demand for bio-based polypropylene in diabetes
management devices is anticipated to contribute significantly to market growth.
Furthermore,
the potential environmental benefits of bio-based polypropylene align with the
broader trend of sustainability in healthcare. The life cycle of medical
devices, from manufacturing to disposal, has come under scrutiny as the
healthcare industry seeks more environmentally responsible practices. Bio-based
polypropylene, derived from renewable resources, offers a pathway towards
reducing the carbon footprint associated with traditional petroleum-based
plastics used in medical devices. This environmental consciousness resonates
with both healthcare providers and consumers, fostering the adoption of bio-based
materials in medical device manufacturing.
The
COVID-19 pandemic has underscored the critical role of medical devices in
healthcare systems worldwide. The demand for bio-based polypropylene in medical
devices has also been influenced by the increased focus on infection prevention
and control. The material's potential for use in single-use disposable medical
devices, such as syringes and protective barriers, aligns with the heightened
awareness of hygiene and safety measures, contributing to the growth of the
bio-based polypropylene market.
In
conclusion, the increasing prevalence of chronic diseases is a key driver
propelling the growth of the global bio-based polypropylene in medical devices
market. The material's versatility, biocompatibility, and potential for
environmental sustainability position it as a valuable choice in the
development of medical devices aimed at addressing the challenges posed by
chronic health conditions. As the healthcare industry continues to innovate in
the face of a rising burden of chronic diseases, the adoption of bio-based
polypropylene is expected to play a pivotal role in shaping the future of
medical device manufacturing, with a focus on improved patient outcomes and
sustainable healthcare practices.
Growing Awareness of the
Benefits of Bio- Polypropylene Propels Global Bio-based
Polypropylene in Medical Devices Market Growth
The
global bio-based polypropylene in medical devices market is experiencing a
significant growth trajectory, propelled by the increasing awareness of the
benefits associated with this sustainable material. Bio-based polypropylene,
derived from renewable feedstocks, has garnered attention in the medical device
manufacturing sector due to its unique combination of biocompatibility,
versatility, and environmental advantages. As awareness grows regarding the
environmental impact of traditional plastics and the need for more sustainable
healthcare practices, the demand for bio-based polypropylene in medical devices
is on the rise.
One
of the primary drivers behind the expanding use of bio-based polypropylene in
medical devices is the heightened awareness of environmental sustainability
within the healthcare industry. The conventional plastics historically used in
medical device manufacturing, often derived from fossil fuels, contribute to
environmental pollution and pose challenges in terms of waste disposal.
Bio-based polypropylene addresses these concerns by offering a renewable and
more eco-friendly alternative. As healthcare organizations and professionals
become increasingly conscious of their ecological footprint, the adoption of
bio-based polypropylene aligns with broader sustainability goals.
The
biocompatibility of bio-based polypropylene is a key factor contributing to its
popularity in medical device applications. The material's compatibility with
the human body makes it suitable for use in implantable medical devices,
prosthetics, and other applications where direct contact with biological
tissues is involved. The growing awareness of the biocompatibility of bio-based
polypropylene has led to its utilization in various medical devices, ranging
from orthopedic implants to surgical instruments, contributing to improved
patient outcomes and reduced risks of adverse reactions.
In
addition to its biocompatible properties, bio-based polypropylene offers
versatility in medical device design and manufacturing. The material can be
molded into complex shapes, allowing for the production of intricate and
customized medical devices. This flexibility is particularly valuable in the
development of patient-specific implants and devices tailored to individual
anatomies. The awareness of these design possibilities has led to increased
interest and adoption of bio-based polypropylene in the medical device
industry, fostering innovation and advancements in device customization.
The
communication of the environmental benefits associated with bio-based
polypropylene plays a crucial role in driving its adoption in the medical
devices market. Healthcare professionals, patients, and regulatory bodies are
increasingly recognizing the importance of sustainable practices in the
industry. Bio-based polypropylene, by virtue of being derived from renewable
resources, contributes to the reduction of carbon emissions and dependence on
finite fossil fuel resources. As awareness spreads about the positive
environmental impact of choosing bio-based materials, medical device
manufacturers are more inclined to incorporate bio-based polypropylene into
their products.
Moreover,
consumers are becoming more environmentally conscious, influencing purchasing
decisions and creating demand for sustainable products, including medical
devices. Patients are increasingly seeking healthcare solutions that align with
their values, including environmental responsibility. The awareness of the
benefits of bio-based polypropylene resonates with patients who prioritize
sustainable and eco-friendly choices, creating a market pull for medical
devices incorporating this material. This trend is expected to influence
medical device manufacturers to adopt bio-based polypropylene in response to
the growing demand for sustainable and patient-centric healthcare solutions.
The
COVID-19 pandemic has further highlighted the importance of sustainable
practices in healthcare. The increased focus on infection prevention and
control measures has led to a surge in the use of single-use medical devices,
where bio-based polypropylene can play a crucial role. The awareness of the
environmental impact of disposable medical devices has prompted the exploration
of sustainable alternatives, and bio-based polypropylene emerges as a viable
solution in this context.
In
conclusion, the growing awareness of the benefits of bio-based polypropylene is
a key driver propelling the growth of the global bio-based polypropylene in
medical devices market. The material's biocompatibility, versatility, and
positive environmental impact align with the evolving values of the healthcare
industry and consumers. As awareness continues to spread regarding the
advantages of adopting sustainable materials in medical device manufacturing,
the demand for bio-based polypropylene is expected to increase, driving
innovation and fostering a more sustainable future for the healthcare sector.
Download Free Sample Report
Key Market Challenges
High Cost of Bio-based
Polypropylene Poses a Significant Obstacle to Market Expansion
The
inflated cost of bio-based polypropylene poses a significant obstacle to the
market expansion of global bio-based polypropylene in the medical devices
sector. While the demand for sustainable and bio-derived materials in medical
applications is growing, the elevated production costs of bio-based
polypropylene remain a challenge. The intricate processes involved in sourcing
bio-based feedstocks, refining, and manufacturing bio-based polypropylene
contribute to its comparatively higher cost compared to traditional polypropylene.
This
cost disparity creates a barrier to widespread adoption in the medical devices
market, where cost-effectiveness is paramount. Industry stakeholders must focus
on innovative approaches, such as optimizing production processes, exploring
cost-effective sourcing alternatives, and leveraging economies of scale, to
make bio-based polypropylene more competitive. By addressing the challenge of
high costs, the bio-based polypropylene market can better position itself for
sustained growth in the global medical devices sector, aligning with the
increasing emphasis on eco-friendly materials.
Technical Challenges of Using
Bio-based Polypropylene
Technical
challenges associated with the use of bio-based polypropylene present a
significant obstacle to the market expansion of global bio-based polypropylene
in the medical devices sector. While the demand for sustainable materials in
medical applications is on the rise, bio-based polypropylene encounters hurdles
related to its technical properties. Achieving the required level of mechanical
strength, thermal stability, and biocompatibility for medical devices proves
challenging, as bio-based polypropylene may not inherently possess the exact
characteristics as its traditional counterpart.
Overcoming
these technical challenges requires substantial investment in research and
development to refine the material's composition and processing techniques.
Industry stakeholders must collaborate to address these obstacles and ensure
that bio-based polypropylene meets the stringent performance standards demanded
by the medical field. By successfully navigating these technical challenges,
the bio-based polypropylene market can position itself as a viable and
sustainable alternative, fostering growth in the global medical devices sector.
Key Market Trends
Development of New Bio-based
Polypropylene
The
global Bio-based Polypropylene in the Medical Devices market is experiencing a
transformative shift, with a significant trend driving growth being the
development of new bio-based polypropylene materials. As the world increasingly
focuses on sustainable and eco-friendly solutions, the medical devices industry
is embracing the use of bio-based polypropylene to reduce its environmental
impact. This innovative trend involves leveraging plant-derived feedstocks to
produce polypropylene, a versatile polymer widely used in medical devices due
to its excellent chemical resistance, durability, and low toxicity. The
development of bio-based polypropylene not only addresses concerns related to
the use of fossil fuels but also aligns with the global push for greener and
more sustainable materials in healthcare applications.
For
instance, companies are actively exploring bio-based polypropylene as a viable
alternative for manufacturing medical devices such as syringes, surgical
instruments, and packaging materials. The renewable and biodegradable nature of
bio-based polypropylene contributes to a reduced carbon footprint and supports
the circular economy within the medical industry. As regulatory bodies
increasingly emphasize sustainability in healthcare practices, the demand for
bio-based polypropylene in medical devices is expected to grow substantially.
Furthermore,
the development of new bio-based polypropylene variants with enhanced
properties, such as improved mechanical strength and sterilization
compatibility, is driving innovation in the medical devices sector. This trend
not only responds to market demands for sustainable materials but also
positions bio-based polypropylene as a key player in shaping the future of
eco-friendly solutions in the global medical devices market.
Growing Demand for Minimally
Invasive Procedures
The
global Bio-based Polypropylene in the Medical Devices market is witnessing
significant growth, with a pivotal trend driving this expansion being the
growing demand for minimally invasive procedures. As the healthcare industry
increasingly shifts towards less invasive treatment approaches, bio-based
polypropylene emerges as a key player in meeting the unique requirements of
medical devices used in these procedures. The inherent properties of bio-based
polypropylene, including its biocompatibility, flexibility, and resistance to
chemicals, make it well-suited for the manufacturing of medical devices
designed for minimally invasive surgeries.
For
example, bio-based polypropylene is employed in the production of catheters,
endoscopic devices, and surgical instruments used in laparoscopic procedures.
The demand for these devices is propelled by factors such as quicker recovery
times, reduced scarring, and lower post-operative complications associated with
minimally invasive techniques. The adoption of bio-based polypropylene aligns
with the industry's commitment to sustainability and addresses concerns related
to the environmental impact of medical waste generated during these procedures.
Furthermore,
the use of bio-based polypropylene in medical devices supports the development
of lightweight and ergonomic tools, enhancing the precision and maneuverability
required for minimally invasive surgeries. As regulatory bodies emphasize the
importance of biocompatible and sustainable materials in healthcare, the demand
for bio-based polypropylene in medical devices is expected to grow, with a
focus on ensuring patient safety and environmental responsibility.
In
conclusion, the growing demand for minimally invasive procedures is a key trend
shaping the growth of the global Bio-based Polypropylene in Medical Devices
market, as the unique properties of this material align with the evolving needs
of the healthcare industry for innovative and sustainable solutions in the
realm of medical devices.
Segmental Insights
Application Insights
Based on the application, the surgical
mesh segment are projected to experience rapid growth during the forecast
period due to its pivotal role in addressing diverse medical conditions and its
increasing adoption in various surgical procedures. Surgical meshes are widely
utilized in hernia repair, pelvic organ prolapses, and other soft tissue
reconstruction surgeries. As the prevalence of hernias and pelvic organ
prolapse continues to rise globally, the demand for surgical meshes is expected
to surge.
The minimally invasive nature of
surgeries involving surgical meshes contributes to their growing popularity,
offering reduced recovery times and postoperative complications. Advancements
in surgical techniques and an aging population, which is more prone to
conditions requiring surgical intervention, further drive the demand for
surgical meshes.
Moreover, ongoing research and
development activities are leading to innovations in mesh materials and
designs, enhancing their efficacy and safety. As healthcare providers
increasingly recognize the benefits of surgical meshes in improving patient
outcomes and reducing the likelihood of recurrence, the segment is positioned
for accelerated growth. The versatility of surgical meshes in supporting
weakened or damaged tissues and promoting optimal healing makes them an
integral component of modern surgical interventions, fostering the projected
rapid growth during the forecast period.
Download Free Sample Report
Regional Insights
Based on the Region, North America's
dominance in the global bio-based polypropylene (PP) in medical devices market
can be attributed to several key factors that position the region at the
forefront of this industry. One significant driver is the well-established and
technologically advanced healthcare infrastructure in North America,
particularly in the United States and Canada. These countries boast
sophisticated medical facilities and a high level of adoption of advanced
medical technologies, creating a substantial market for bio-based polypropylene
in medical devices.
Stringent regulations and standards in
North America regarding the use of sustainable and environmentally friendly
materials in the healthcare sector contribute to the increased adoption of
bio-based polypropylene. As awareness of the environmental impact of
traditional plastics grows, healthcare providers and manufacturers in the
region are increasingly inclined towards sustainable alternatives, such as
bio-based polypropylene, for medical device production.
Moreover, North America places a strong
emphasis on research and development, fostering innovation in bio-based
materials. The region's commitment to reducing carbon footprints and promoting
eco-friendly solutions aligns with the use of bio-based polypropylene in
medical devices. Government initiatives and incentives further encourage the
incorporation of sustainable materials in healthcare applications.
The robust presence of key players in
the bio-based polypropylene industry, as well as a well-established network of
medical device manufacturers, contributes to North America's dominance.
Proximity to raw material suppliers and a mature market for medical devices
create a conducive environment for the growth of bio-based polypropylene
applications in medical settings.
Overall, the convergence of advanced
healthcare infrastructure, stringent environmental regulations, a focus on
sustainability, and a robust industry ecosystem positions North America as a
dominant player in the global bio-based polypropylene in medical devices
market. This trend is likely to persist as the region continues to prioritize
sustainable practices in healthcare and innovation in materials science.
Recent Developments
- In
2023, Braskem, a prominent polyolefins
producer in the Americas and a global leader in biopolymers, disclosed plans to
assess an investment in the production of carbon-negative bio-based
polypropylene (PP) in the U.S. Leveraging their proven technology, the project
aims to convert bioethanol into segregated bio-based PP, with Braskem actively
seeking partnerships with clients, brand owners, and suppliers.
- In
2023, South Korean chemical company LG Chem has entered into a partnership with
Gevo, an American renewable chemicals and advanced biofuel company. The
collaboration aims to jointly work on the advancement of ethanol-to-olefin
(ETO) technology, a crucial component for the commercialization of propylene
derived from biomaterials.
Key Market Players
- Saudi
Basic Industries Corp
- LyondellBasell
Industries NV
- Mitsui
Chemicals Inc.
- Borealis
AG
- Braskem
SA
- TotalEnergies
SE
- Danimer
Scientific Inc
- FAF
Kunststofftechnik GmbH & Co KG
- GreenMantra
Recycling Technologies Ltd
- Avient
Corporation
|
By
Application
|
By
Region
|
- Heart
Valve Structures
- Surgery
Sutures
- Surgical
Mesh
- Others
|
- North
America
- Europe
- Asia
Pacific
- South
America
- Middle
East & Africa
|
Report Scope:
In this report, the Global Bio-based Polypropylene
in Medical Devices Market has been
segmented into the following categories, in addition to the industry trends
which have also been detailed below:
- Bio-based Polypropylene in Medical Devices Market, By Application:
o Heart Valve Structures
o Surgery Sutures
o Surgical Mesh
o Others
- Bio-based Polypropylene in Medical Devices Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
§ Turkey
§ Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bio-based
Polypropylene in Medical Devices Market.
Available Customizations:
Global Bio-based Polypropylene in Medical Devices market report with the given market
data, Tech Sci Research offers customizations according to a company's specific
needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Bio-based
Polypropylene in Medical Devices Market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]